Becton Dickinson Declares $.22 Quarterly Dividend

May 24, 2006

NEW YORK, May 23 (GenomeWeb News) - Becton Dickinson's board of directors declared a quarterly dividend of $0.215 per common share, the company said yesterday.

The dividend will be payable on June 30 to holders of record on June 9. The indicated annual dividend rate is $0.86 per share.

Breaking News

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.

Becton Dickinson Declares $.22 Quarterly Dividend

Quidel Q1 Revenues More Than Double but Miss Expectations

Twist Bioscience Q2 Revenues Grow 62 Percent

Natera Q1 Revenues Grow 62 Percent

T2 Biosystems Q1 Revenues Nearly Triple

Fluidigm Q1 Revenues Grow 19 Percent

NantHealth Q1 Revenues Decline 11 Percent

US Supports Patent Waivers

Vaccines Versus Variants

CRISPR for What Ails You

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

Oxford Nanopore Technologies Raises £195M

NeoGenomics to Acquire Inivata for $390M as Q1 Revenues Grow 9 Percent

Wasted Doses

Labcorp to Acquire Myriad Genetics' Vectra Rheumatoid Arthritis Test for $150M

Eli Broad Dies